Cuba's Abdala vaccine against Covid-19 shows favorable results
Cuba's Abdala vaccine against Covid-19 shows favorable results
Havana, Jan 26 (Prensa Latina) Cuba's Abdala vaccine candidate demonstrated its safety and immunogenicity against Covid-19, leaders of the study highlighted on Tuesday.
On Twitter, the president of the Business Group of Biotechnological and Pharmaceutical Industries (BioCubaFarma), Eduardo Martinez, detailed that an independent committee for the data analysis of the clinical trial verified those results.
Developed by the Center for Genetic Engineering and Biotechnology (CIGB), Abdala began on December 2nd the first phase of the clinical study with 200 volunteers at the Saturnino Lora Hospital, in the eastern province of Santiago de Cuba.